Main Navigation

Pediatric Oncology Branch Home > Pediatric Psycho-Oncology Professionals > Profiles > Daniel Armstrong

Headline Title

Pediatric Psycho-Oncology Professionals

Daniel Armstrong

First Name: Daniel

Last Name: Armstrong

Position Title: Professor & Executive Vice Chair, Department of Pediatrics; Director, Mailman Center for Child Development and Director, University of Miami Sickle Cell Center, University of Miami Miller School of Medicine

Associate Chief of Staff, Holtz Children's Hospital

Job Responsibilities: Combination of Research and Patient Care, Department & Hospital Leadership/Administration

Education/Training: Psychology

About Me/My interests: My research focuses on neurodevelopmental outcomes of childhood cancer, sickle cell disease, HIV. The current efforts are on identifying biologic (e.g, chronic anemia, chronic inflammatory processes, and biochemical pathway disruptions) and genetic risk factors for neurocognitive outcomes to better understand mechanisms that can be modified, and developing and evaluating innovative approaches to intervention and prevention. We are beginning to look at outcomes in adults who are long-term survivors of these chronic illnesses, and at models of clinical-community and community-public policy translation research, particularly in the area of health disparities.

Training Opportunities: Yes

My Contact Information:
Address: P.O. Box 016820 (D-820), Miami, FL 33101
Email: darmstrong@miami.edu
Phone: 305-243-6801

Topics of Interest for Collaboration: Neurocognitive outcomes, childhood cancer, sickle cell disease, health disparities, translation research

Publications that may be of interest to others:  

Wang, W.C., Ware, R.E., Miller, S.T., Iyer, R.V., Casella, J.F., Minniti, C.P., Rana, S., Thornburg, C.D., Rogers, Z.R., Kalpatthi, R.V., Barredo, J.C., Brown, R.C., Sarnaik, S.A., Howard, T.H., Wynn, L.W., Kutlar, A., Armstrong, F.D., Files, B.A., Goldsmith, J.C., Xuang, X., & Thompson, B.W. for the BABY HUG Investigators. (2011). Hydroxycarbamide in very young children with sickle cell anaemia: A multicentre, randomised, controlled trial (BABY HUG). The Lancet, 377, 1663-1672.

Vichinsky, E.P, Neumayr, L.D., Gold, J.I., Weiner, M.W., Rule, R.R., Truran, D., Kastan, J., Eggleston, B., Kessler, K., McMahon, L., Orringer, E.P., Harrington, T., Kalinyak, K., De Castro, L.M., Rutherford, C.J., Johnson, C., Bessman, J.D., Jordan, L.B., & Armstrong, F.D. (2010). Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adult patients with sickle cell anemia. Journal of the American Medical Association, 303(18), 1823-1831.

Ris, M.D., Beebe, D.W., Armstrong, F.D., Fontanesi, J., Mulhern, R.K., Holmes, E., & Wisoff, J.H. (2008). Cognitive and adaptive outcome in extracerebellar low grade brain tumors in children from a national collaborative study (CCG 9891/POG 9130): A report from the Children’s Oncology Group. Journal of Clinical Oncology, 26, 4765-70.

Nathan, P.C., Patel, S., Dilley, K., Goldsby, R., Harvey, J., Jacobsen, C., Kadan-Lottick, N., McKinley, K., Millham, A.K., Moore, I., Okcu, M.F., Woodman, C.L., Brouwers, P., & Armstrong, F.D. (2007). Neurocognitive and Behavioral Problems in Survivors of Childhood Cancer: Guidelines for Identification, Advocacy and Intervention. Archives of Pediatrics and Adolescent Medicine, 161 (8), 798-806.

Armstrong, F.D. (2006). Neurodevelopment and chronic illness: Mechanisms of disease and treatment. Mental Retardation and Developmental Disabilities Research Reviews, 12, 168-173.

 

return to the top